A detailed history of Kovitz Investment Group Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 68,358 shares of ABBV stock, worth $12.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
68,358
Previous 23,022 196.92%
Holding current value
$12.3 Million
Previous $3.95 Million 241.92%
% of portfolio
0.09%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $7.43 Million - $9.04 Million
45,336 Added 196.92%
68,358 $13.5 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $1.27 Million - $1.48 Million
8,190 Added 55.22%
23,022 $3.95 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1.22 Million - $1.39 Million
7,633 Added 106.03%
14,832 $2.7 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $31,372 - $35,333
-228 Reduced 3.07%
7,199 $1.12 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $1,469 - $1,701
-11 Reduced 0.15%
7,427 $1.11 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $818,116 - $1.02 Million
-6,174 Reduced 45.36%
7,438 $1 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $724,496 - $834,365
-5,010 Reduced 26.9%
13,612 $2.17 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $60,718 - $72,816
-439 Reduced 2.3%
18,622 $3.01 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $243,725 - $279,536
-1,816 Reduced 8.7%
19,061 $2.56 Million
Q2 2022

Aug 02, 2022

SELL
$137.62 - $174.96 $1.84 Million - $2.34 Million
-13,360 Reduced 39.02%
20,877 $3.2 Million
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $4 Million - $4.97 Million
-30,337 Reduced 46.98%
34,237 $5.55 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $1.15 Million - $1.45 Million
10,699 Added 19.86%
64,574 $6.92 Million
Q3 2021

Oct 28, 2021

SELL
$106.4 - $120.78 $2.22 Million - $2.52 Million
-20,904 Reduced 27.95%
53,875 $5.81 Million
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $1.57 Million - $1.75 Million
14,950 Added 24.99%
74,779 $8.42 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $469,966 - $517,376
-4,594 Reduced 7.13%
59,829 $6.48 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $773,025 - $1.04 Million
-9,604 Reduced 12.97%
64,423 $6.9 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $241,493 - $283,433
2,811 Added 3.95%
74,027 $6.48 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $2.42 Million - $3.23 Million
32,920 Added 85.96%
71,216 $6.99 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $2.1 Million - $3.18 Million
-32,567 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $2.35 Million - $2.94 Million
32,567 New
32,567 $2.88 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $729,119 - $876,610
-11,577 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $103,017 - $131,680
-1,568 Reduced 11.93%
11,577 $842,000
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $44,201 - $52,022
573 Added 4.56%
13,145 $1.06 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $42,817 - $52,805
-550 Reduced 4.19%
12,572 $1.16 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $53,523 - $59,501
602 Added 4.81%
13,122 $1.24 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $48,481 - $57,364
-540 Reduced 4.13%
12,520 $1.16 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $1.04 Million - $1.39 Million
-11,292 Reduced 46.37%
13,060 $1.24 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $38,063 - $41,739
-425 Reduced 1.72%
24,352 $2.36 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $1.73 Million - $2.21 Million
24,777
24,777 $2.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kovitz Investment Group Partners, LLC Portfolio

Follow Kovitz Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.